Senores Pharmaceuticals Capacity Expansion: ₹18 Cr Investment

Senores Pharmaceuticals Other Announcement

Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.

Value

₹95.00 Cr

Senores Pharmaceuticals Capacity Expansion: ₹20 Cr Investment

Senores Pharmaceuticals' subsidiary Apnar Pharma Private Limited plans a 0.7 Bn unit capacity addition by March 2027. The investment is Rs.20.00 Crore, funded by internal accruals and IPO proceeds.

Value

₹20.00 Cr

Execution

By end of March 2027

production capacity

0.7 Bn units

Senores Pharmaceuticals Other Announcement

Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.

Execution

60 months

Senores Pharmaceuticals Investor Presentation: Key Takeaways

Q2 FY27 revenue ₹192.3 Cr (+24.9%), EBITDA ₹57.7 Cr (+38.3%, 30.0% margin), PAT ₹36.6 Cr. H1 revenue +30%, EBITDA +58.2%.

Senores Pharmaceuticals Results Update

Senores reported Q2 FY27 revenue of ₹192 cr and EBITDA of ₹58 cr, both record highs. PAT grew 22% Y-o-Y to ₹37 cr with positive FY27 outlook.

Senores Pharmaceuticals Capacity Expansion: ₹43 Cr Investment

Senores Pharmaceuticals disclosed capacity expansion at three subsidiaries with total estimated cost of ₹43 Crore. Expansions adding ~1.5 Bn units/annum are expected by March 2027.

Value

₹43.00 Cr

Execution

By end of March 2027

manufacturing capacity addition (per annum)

1502.7 Mn units

FlySBS Aviation Capacity Expansion: ₹13.98 Cr Investment

FlySBS Aviation will induct a Hawker 900XP 9-seater aircraft in October 2026, funded by Rs.13.98 Crore from IPO proceeds. Fleet rises from two to three aircraft.

Value

₹13.98 Cr

Execution

October 2026

fleet capacity (9-seater aircraft)

1.0 aircraft

Greenply Industries Capacity Expansion: ₹30 Cr Investment

Greenply's board approved further investment of up to INR 30 crore in its wholly owned subsidiary Greenply Sandila Private Limited for plywood capacity expansion. The funds will be paid in one or more tranches by Q4 FY2028.

Value

₹30.00 Cr

Execution

Q4 of FY 2028, in one or more tranches

Ethos Capacity Expansion

Ethos has opened a new Ethos Summit boutique at Fort, Mumbai, taking its total to 105 boutiques across India. The filing is an update on a store opening with no monetary value disclosed.

new boutiques

1.0 boutiques

Greenply Industries Capacity Expansion

Greenply's board noted a 15 million sq mtr plywood capacity expansion at subsidiary Greenply Sandila, due by Q4 FY2028. Approximately Rs. 125 crore investment is planned.

Execution

By Q4 of FY 2028

plywood manufacturing capacity

15.0 million sq mtr

EPack Prefab Technologies Capacity Expansion: ₹100 Cr Investment

EPack Prefab plans to add 11,300 MT of PEB and 8,00,000 sq m of PUF capacity. The ₹100 Crore investment will be funded from IPO proceeds.

Value

₹100.0 Cr

Execution

Period stated as 28-10-2026 in the filing (date as filed; the period is not otherwise defined)

PEB structures capacity addition

11300.0 MTPA

EPack Prefab Technologies Capacity Expansion

Epack Prefab added 11,300 MTPA PEB and 8,00,000 sq m PUF capacity from October 28, 2026. The Rs.100 Crore project uses IPO net proceeds.

PEB structures capacity addition

11300.0 MTPA